OCI NV (OCI.AS)

NL0010558797 - Common Stock

22.12  -0.16 (-0.72%)

Fundamental Rating

1

Taking everything into account, OCI scores 1 out of 10 in our fundamental rating. OCI was compared to 63 industry peers in the Chemicals industry. Both the profitability and financial health of OCI have multiple concerns. OCI has a expensive valuation and it also scores bad on growth.



Quickly go to:

1

1. Profitability

1.1 Basic Checks

OCI had negative earnings in the past year.
In the past year OCI had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: OCI reported negative net income in multiple years.
Each year in the past 5 years OCI had a positive operating cash flow.

1.2 Ratios

OCI has a Return On Assets of -7.10%. This is in the lower half of the industry: OCI underperforms 79.03% of its industry peers.
With a Return On Equity value of -68.84%, OCI is not doing good in the industry: 91.94% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -7.1%
ROE -68.84%
ROIC N/A
ROA(3y)4.7%
ROA(5y)1.72%
ROE(3y)13.16%
ROE(5y)-0.18%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

OCI has a Gross Margin of 6.73%. This is amonst the worse of the industry: OCI underperforms 88.71% of its industry peers.
OCI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 6.73%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

2

2. Health

2.1 Basic Checks

OCI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, OCI has about the same amount of shares outstanding.
Compared to 5 years ago, OCI has more shares outstanding
The debt/assets ratio for OCI has been reduced compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of 0.82, we must say that OCI is in the distress zone and has some risk of bankruptcy.
OCI has a worse Altman-Z score (0.82) than 85.48% of its industry peers.
The Debt to FCF ratio of OCI is 30.10, which is on the high side as it means it would take OCI, 30.10 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 30.10, OCI is not doing good in the industry: 61.29% of the companies in the same industry are doing better.
A Debt/Equity ratio of 2.51 is on the high side and indicates that OCI has dependencies on debt financing.
OCI has a Debt to Equity ratio of 2.51. This is amonst the worse of the industry: OCI underperforms 96.77% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.51
Debt/FCF 30.1
Altman-Z 0.82
ROIC/WACCN/A
WACC6.09%

2.3 Liquidity

A Current Ratio of 1.58 indicates that OCI should not have too much problems paying its short term obligations.
With a Current ratio value of 1.58, OCI is not doing good in the industry: 67.74% of the companies in the same industry are doing better.
A Quick Ratio of 1.55 indicates that OCI should not have too much problems paying its short term obligations.
OCI's Quick ratio of 1.55 is fine compared to the rest of the industry. OCI outperforms 72.58% of its industry peers.
Industry RankSector Rank
Current Ratio 1.58
Quick Ratio 1.55

More info and screens

1

3. Growth

3.1 Past

OCI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -111.52%.
OCI shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -53.13%.
The Revenue has been decreasing by -9.61% on average over the past years.
EPS 1Y (TTM)-111.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%336.11%
Revenue 1Y (TTM)-53.13%
Revenue growth 3Y-17.33%
Revenue growth 5Y-9.61%
Sales Q2Q%-10.72%

3.2 Future

OCI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 22.03% yearly.
OCI is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -15.48% yearly.
EPS Next Y146.14%
EPS Next 2Y90.24%
EPS Next 3Y59.2%
EPS Next 5Y22.03%
Revenue Next Year-33.54%
Revenue Next 2Y-14.48%
Revenue Next 3Y-7.14%
Revenue Next 5Y-15.48%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

OCI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 19.18, which indicates a rather expensive current valuation of OCI.
OCI's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 20.59. OCI is around the same levels.
Industry RankSector Rank
PE N/A
Fwd PE 19.18

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, OCI is valued a bit more expensive than 61.29% of the companies in the same industry.
Industry RankSector Rank
P/FCF 62.32
EV/EBITDA N/A

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as OCI's earnings are expected to grow with 59.20% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y90.24%
EPS Next 3Y59.2%

More info and screens

0

5. Dividend

5.1 Amount

OCI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

OCI NV

AMS:OCI (7/26/2024, 7:00:00 PM)

22.12

-0.16 (-0.72%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap4.67B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 19.18
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.1%
ROE -68.84%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 6.73%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.69
Health
Industry RankSector Rank
Debt/Equity 2.51
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.58
Quick Ratio 1.55
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-111.52%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y146.14%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-53.13%
Revenue growth 3Y-17.33%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y